Petros Pharmaceuticals (PTPI) Stock Statistics & Valuation Metrics

Petros Pharmaceuticals has a market cap or net worth of $938.54K. The enterprise value is -$8.00M.

Petros Pharmaceuticals has 31,160,086 shares outstanding. The number of shares has decreased by -2.65% in one year.

Petros Pharmaceuticals’s return on equity (ROE) is 1.92 and return on invested capital (ROIC) is 21749.66%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Petros Pharmaceuticals had revenue of 5.11M and earned -14.32M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was 1.43M and capital expenditures 0.00, giving a free cash flow of 1.43M billion.

Petros Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Petros Pharmaceuticals upcoming earnings date is ―, ―.

Petros Pharmaceuticals as a current ratio of 0.40, with Debt / Equity ratio of 0.00%

In the past 12 months, Petros Pharmaceuticals has paid 0.00 in taxes.

Petros Pharmaceuticals EV to EBITDA ratio is -7.65, with an EV/FCF ratio of -31.49.

Petros Pharmaceuticals has $8.93M in cash and marketable securities with $7.25M in debt, giving a net cash position of -$1.68M billion.

Gross margin is 76.34%, with operating margin of -345.84%, and net profit margin of -280.10%.

The average price target for Petros Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy